BIO-Europe 2026
Panel Therapeutic Insights track
The next oncology winners: Where investors, pharma and biotech are placing their bets
Mon, Nov 9, 2026 · 3:00–3:45 PM CET Therapeutic Insights Stage, Koelnmesse
About this session
Oncology remains the largest and most competitive area of biotech innovation, but the path to success is becoming increasingly complex. Emerging modalities such as radioligand therapies, next-generation immunotherapies, cell therapies and precision-targeted approaches are generating significant excitement, yet investors and pharmaceutical companies are becoming more selective in how they evaluate risk, differentiation and commercial potential.
